Filing Details

Accession Number:
0001138723-10-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-27 13:00:00
Reporting Period:
2010-05-26
Filing Date:
2010-05-27
Accepted Time:
2010-05-27 18:10:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138723 Accuray Inc ARAY Surgical & Medical Instruments & Apparatus (3841) 770268932
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1387516 Euan Thomson 1310 Chesapeake Terrace
Sunnyvale CA 94089
President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-26 12,500 $0.75 47,500 No 4 M Direct
Common Stock Disposition 2010-05-26 12,500 $5.97 35,000 No 4 S Direct
Common Stock Acquisiton 2010-05-26 10,000 $1.40 45,000 No 4 M Direct
Common Stock Acquisiton 2010-05-27 12,500 $0.75 57,500 No 4 M Direct
Common Stock Disposition 2010-05-27 12,500 $6.23 45,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2010-05-26 12,500 $0.00 12,500 $0.75
Common Stock Incentive Stock Option (right to buy) Disposition 2010-05-27 12,500 $0.00 12,500 $0.75
Common Stock Incentive Stock Option (right to buy) Disposition 2010-05-26 10,000 $0.00 10,000 $1.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
320,832 2012-03-28 No 4 M Direct
308,332 2012-03-28 No 4 M Direct
12,500 2014-03-16 No 4 M Direct
Footnotes
  1. A portion of these options are being sold so that a portion of the proceeds may be used to increase the CEO's ownership of Accuray stock in anticipation of the adoption of stock ownership guidelines for management by the Board of Directors of Accuray Incorporated in fiscal year 2011.
  2. A total of 12,500 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $5.9746 per share. The actual sale price for the shares was: 100 shares at $5.87; 100 shares at $5.92; 400 shares at $5.93; 600 shares at $5.94; 1500 shares at $5.95; 1800 shares at $5.96; 2000 shares at $5.97; 500 shares at $5.98; 1800 shares at $5.99; 3500 shares at $6.00; and 200 shares at $6.01.
  3. A total of 12,500 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $6.1073 per share. The actual sale price for the shares was: 1000 shares at $5.99; 100 shares at $6.00; 100 shares at $6.04; 800 shares at $6.05; 179 shares at $6.06; 300 shares at $6.08; 121 shares at $6.09; 1556 shares at $6.10; 100 shares at $6.1050; 1193 shares at $6.11; 1451 shares at $6.12; 1800 shares at $6.13; 300 shares at $6.1350; 1500 shares at $6.14; 600 shares at $6.1450; 500 shares at $6.15; and 900 shares at $6.16.
  4. The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.
  5. These options are exercisable as they vest. The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months.